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Insulin is essential for glucose homeostasis, but reducing its activity delays the aging process in model
organisms. In this issue of Cell Metabolism, Lee et al. (2009) show how these effects of insulin signaling inter-
sect when glucose is fed to C. elegans.Insulin has essential functions as an
anabolic hormone and in maintenance of
glucose homeostasis. After consumption
of food, particularly sugary foods, blood-
stream glucose levels rise. This triggers
release of insulin, which stimulates glu-
cose uptake (Figure 1) (Shepherd and
Kahn, 1999). Under conditions of insulin
insufficiency or resistance, circulating
glucose levels are elevated, eventually
leading to damage in vascular and renal
tissues and other diabetic complications.
A major cause of this damage is an
increase in intracellular reactive oxygen
species (ROS) resulting from metabolic
perturbations associated with hypergly-
cemia (Brownlee, 2005).
While insulin is essential for survival, it
also seems to play a role in aging. Studies
inmodel organismshaveshown that aging
can be delayed by reductions in signaling
from insulin or related factors (insulin-like
signaling) (Russell and Kahn, 2007). Spe-
cifically, insulin-like signaling inhibits the
transcription factor FOXO (DAF-16 in
C. elegans), which acts to promote stress
resistanceandhealthy longevity (Figure1).
Analyses of knockout mice and long-lived
human cohorts support a link between
reduced insulin signaling, FOXO, and
longevity (Russell and Kahn, 2007; Lee
et al., 2009), suggesting that this longer
life might be available not only to simple
organisms like nematodes, but also to
us. The question remains, however: how
can the essential functions of insulin be
reconciled with the expected benefits of
lowering its activity? In this issue of Cell
Metabolism, Lee et al. (2009) begin to
unravel how these insulin functions influ-
ence each other. They show that high
glucose levels shorten C. elegans life
span by increasing insulin-like signaling
and that glycerol may be an important
mediator of glucose metabolism.338 Cell Metabolism 10, November 4, 2009 ªAs numerous studies have investigated
how insulin-like signaling affects lon-
gevity, it is reassuring to see compelling
evidence that glucose decreases life
span by acting on this pathway in the
organism where this story originated (Lee
et al., 2009). Glucose feeding reduced
life span in wild-type animals and essen-
tially negated the longevity benefits asso-
ciated with either mutations in the insulin
receptor DAF-2 or RNA interference
(RNAi) against the insulin-like peptide
INS-7.While this reductionofdaf-2mutant
life span might seem to suggest a daf-2-
independent effect of glucose, it must be
remembered that the insulin receptor is
only partially impaired in these mutants,
so that increased insulin activity deriving
from elevated glucose would likely be
devastating. Glucose also inhibited the
propensity of daf-2 mutants to develop
into dauer larvae, a diapause state that
allows the animal to withstand adverse
conditions. Importantly, glucose did not
further reduce the truncated life spans
associated with the absence of either
DAF-16 or heat shock factor (HSF-1),
which cooperates with DAF-16. Finally,
glucose increased expression of several
insulin-like genes and led to other gene
expression changes that overlapped with
effects of inhibiting DAF-16.
One of the genes downregulated by
both glucose and DAF-16 is aqp-1, which
encodes an aquaporin glycerol channel
(Lee et al., 2009). Lack of aqp-1mimicked
many effects of glucose, including reduc-
tion of wild-type but not daf-16() life
span, downregulation of DAF-16 and
HSF-1 targets, upregulation of ins-7, and
modulation of DAF-16 activity. Glycerol
was elevated by glucose feeding and
also reduced life span, suggesting that
AQP-1 and glycerol may function down-
stream of glucose in a pathway that2009 Elsevier Inc.affects life span through insulin-like
signaling. These provocative results
suggest that glycerol might be involved
in glucose metabolism in mammals. In
mice, aquaporin channels allow move-
ment of glycerol from adipocytes to
the liver (both corresponding to the
C. elegans intestine), and knockout of an
adipocyte aquaporin channel is associ-
ated with abnormal glycerol metabolism,
insulin resistance, and obesity (Maeda
et al., 2008).
Other recent studies have also shown
that glucose feeding shortens C. elegans
life span, but suggested involvement of
additional mechanisms (Schlotterer
et al., 2009; Schulz et al., 2007). Schulz
et al. (2007) reported that a glucose
mimetic that cannot be metabolized
increases life span, an effect attributed
to stress-pathway stimulation by ROS
arising from increased respiration. ROS
are also increased by glucose, however
(Schlotterer et al., 2009), indicating that
further analysis will be required to under-
stand thepossibleeffectsofglucosemeta-
bolic pathways on longevity. In the latter
study, overexpression of glyoxalase-1
protected against the life span-shortening
effects of glucose. This enzyme detoxifies
methylglyoxal, a glucose metabolite
involved in diabetic complications. This
observation should also be explored
further, because only one transgenic strain
was analyzed, but it suggests that
C. elegans might be amenable to analysis
of glucose toxicity mechanisms that lead
to diabetic complications.
While caution should be exercised in
extrapolating fromsimplemodelorganisms
to people, the results of Lee et al. (2009)
could have profound implications for
understanding how insulin affects us.While
the ‘‘good’’ effects of insulin are undoubt-
edly essential, including prevention of
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PreviewsFigure 1. Effects of Glucose on Insulin-like Signaling and Longevity
Glucose stimulates release of insulin, which induces glucose uptake. Insulin-like signaling also inhibits
FOXO/DAF-16, which positively regulates aqp-1 and other stress resistance and longevity genes. High
glucose levels may increase cellular ROS. In C. elegans, these events all appear to occur in the intestine,
although insulin-like signaling responses vary among tissues.hyperglycemia and resultant tissue
damage, it seems that one might want to
get by with needing as little insulin as
possible, in order to minimize its inhibition
of the life span-extending effects identified
in animal models. The present study may
also have implications for understandingA Tale of Two Car
Malcolm J. Low1,*
1Departments of Molecular & Integrative Phys
University of Michigan, Ann Arbor, MI 48109-5
*Correspondence: mjlow@umich.edu
DOI 10.1016/j.cmet.2009.10.005
Proopiomelanocortin (Pomc) neuro
Pomc posttranslational processing,
mentary papers that zero in on dist
refocus the spotlight on regulated p
Hypothalamicproopiomelanocortin (Pomc)
neuronal circuits play a critical role in
tightly matching body weight to a fixed
set point, primarily by inhibiting appetite
and feeding behavior (Cone, 2005).
Multiple regulatory steps in Pomc biosyn-
thesis ultimately determine Pomc-derivedeffects of calorie restriction, a condition
that prolongs life in essentially every
organism examined (Bishop andGuarente,
2007). By identifying a specific life span-
inhibitory effect of glucose, its results raise
the question of whether the effects of
limiting calories and glucose might beboxypeptidases
iology and Internal Medicine, Brehm Center for
622, USA
ns play a central role in energy hom
regulation of Pomc gene expression
inct carboxypeptidases (Plum et al.,
eptide cleavage.
peptide tone in the CNS in response to
hormonal, metabolic, and trans-synaptic
inputs toPomcneurons (Figure 1). Indeed,
Pomc has served as a paradigm for inves-
tigating posttranslational processing of
prohormones into multiple bioactive
peptides (Pritchard and White, 2007).
Cell Metabolism 10distinguishable. Evidently, we can’t have
our cake and eat it too just yet, but hope
remains that a better understanding of
how low insulin activity increases life span
could allow these prolongevity mecha-
nisms to be harnessed without impairing
the essential activities of insulin. In the
meantime, this work provides additional
motivation to skip dessert.
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